We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

National Cancer Institute Awards Two Lung Cancer CTC Development Contracts to Cynvenio Biosystems, Inc.

News   Feb 07, 2012

 
National Cancer Institute Awards Two Lung Cancer CTC Development Contracts to Cynvenio Biosystems, Inc.
 
 
Advertisement
 

RELATED ARTICLES

Switching Immune Cells From “Protect” to “Attack” Mode To Treat Prostate Cancer

News

Researchers found that immune cells called macrophages, which are typically found in prostate cancer tumors to help promote growth, can be rewired to attack the disease using therapeutics.

READ MORE

Chemo-induced Changes in Tumors Trigger Blood Vessel Anomalies

News

Scientists have identified how inflammatory alterations in tumors caused by chemotherapy treatment trigger blood vessel anomalies and thus drug-resistance, resulting in poor prognosis of cancer patients.

READ MORE

SARS-CoV-2 Immunity Likely To Be Higher Than Antibody Testing Has Shown

News

A recent study suggests that many people who contract SARS-CoV-2 but have mild or no clinical signs still develop so-called T-cell-mediated immunity to the virus, even in the absence of a positive antibody test. The researchers conclude that this is likely to mean that public immunity is probably higher than antibody testing has so far suggested.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE